Phaarmasia Ltd Share Price

₹108.41 2.12 (1.99%) BSE
as updated on 24-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:108.41
  • Day's High:108.41

  • 52 Week Low23.60
  • 52 Week High106.29

Phaarmasia Ltd's key Fundamentals

Market Cap ₹73 Cr.
P/E Ratio 93
TTM EPS 1.1
P/B Ratio 11.16
ROE -16.70
Debt to Equity 0.00
Face Value 10
BVPS 9.5
3 Year Sales Growth 12.27%

Phaarmasia Ltd's Share Price Returns

1 Day 1.99%
1 Week 10.40%
1 Month 110.40%
3 Months 198.90%
6 Months 219.60%
1 Years 89.40%
3 Years 273.80%
5 Years 258.40%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Phaarmasia Ltd Shareholding Pattern

Promoters

(73.51%)

Institutions

(0.06%)

Non-Institutions

(26.43%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Phaarmasia Ltd

The company was incorporated on  February 6,1981 as Phaarmasia Private Limited, and the company was converted into a public limited company, Phaarmasia Limited on February 15, 1992, it is into manufacturing of pharmaceutical formulations. Company's facilities are spread over in 3 acres of land with built up area of 90,000 sq.ft.

The company was established for  carrying on the business as manufacturers, buyers, sellers, importers, exporters, distributors, agents and or otherwise deal as wholesalers, or retailers in drugs, medicines, pharmaceuticals, chemicals and other intermediates, dyes pigments, paints, rubber chemicals, phyto chemicals, hormones, agro-chemicals, veterinary and poultry products, food and nutritional products, house-hold remedies, biological and herbal products.

Phaarmasia’s registered office is located at 16,Phase III, I.D.A Jeedimetla, Hyderabad, Andhra Pradesh 500 055, India.

The company had restructured its Paid up Share Capital account of 91,34,800 Equity Shares of Rs 10 each fully paid up as on 31st, March,2005 by reducing / debiting the amount of Rs 730.78 lakhs for setting off the Accumulated Losses of the Company and has further allotted 50,00,000 Equity Shares of Rs 10each to promoters and Associates for Rs 250 lakhs and balance to Unsecured Creditors as approved in the above Scheme of Arrangement.

Product range of the company includes:

Phaarmasia’s product range includes amexine, angicare, flamfort, nasorel, flemkof, ginadox, medix and ziron. Its amexine is an antibiotic, which is used for upper respiratory tract infections, mucolytic and expectorant.

Company also provides nasorel PR, which is a therapeutic category that comes under antihistamine and sympathomimetic.

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 108.41
  • Day's High: 108.41

  • 52 Week Low23.60
  • 52 Week High106.29

Phaarmasia Ltd's key Fundamentals

Market Cap ₹73 Cr.
P/E Ratio 93
TTM EPS 1.1
P/B Ratio 11.16
ROE -16.70
Debt to Equity 0.00
Face Value 10
BVPS 9.5
3 Year Sales Growth 12.27%

Phaarmasia Ltd's Share Price Returns

1 Day 1.99%
1 Week 10.40%
1 Month 110.40%
3 Months 198.90%
6 Months 219.60%
1 Years 89.40%
3 Years 273.80%
5 Years 258.40%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×